58 / 100

Dr. Takeshi Chiba | Life Sciences | Best Researcher Award

Associate Professor at Juntendo University, Japan

Dr. Takeshi Chiba is an Associate Professor and Assistant Director at Juntendo University’s Laboratory of Clinical Pharmacology and Department of Pharmacy. He earned his pharmacist’s license in 1999 and a Ph.D. in Pharmaceutical Sciences in 2002 from Josai University. His professional journey includes roles at Iwate Medical University Hospital, Iwate Medical University, Hokkaido University of Science, and Juntendo University. Dr. Chiba’s research focuses on the physiological functions of mammary epithelial cells during lactation, including the synthesis of norepinephrine and the effects of psychological stress and smoking on milk composition. His contributions have led to significant findings in cell biology and pharmacology, reflected in 42 published journal articles and numerous awards. He is a member of several professional societies and has been recognized for his work with academic awards and publications.

Professional Profiles:

🎓 Education

Dr. Takeshi Chiba earned his Pharmacist’s license from Josai University in Saitama, Japan, in March 1999. He then pursued advanced studies at the same institution, culminating in a Ph.D. in Pharmaceutical Sciences, which he completed in March 2002.

Professional Experience

Dr. Takeshi Chiba began his career as a pharmacist at Iwate Medical University Hospital in Japan, serving from April 2002 to March 2009. He transitioned to an academic role as an Assistant Professor in the Department of Clinical Pharmaceutics at Iwate Medical University from April 2009 to March 2019. He then moved to Hokkaido University of Science, where he was a Lecturer in the Department of Clinical Pharmaceutics from April 2019 to March 2023. Since April 2023, Dr. Chiba has been serving as an Associate Professor in the Laboratory of Clinical Pharmacology at the Faculty of Pharmacy, Juntendo University, while also holding the position of Assistant Director at the Department of Pharmacy, Juntendo University Hospital.

Research Interest

Dr. Takeshi Chiba’s research interests focus on clinical pharmacology, particularly the physiological and biochemical aspects of lactation and its impact on infant health. His notable research includes the discovery that mammary epithelial cells synthesize and secrete norepinephrine into milk during lactation, a previously unknown function. He also investigates the effects of psychological stress on microRNA expression in milk, specifically how decreased miR-148a levels influence intestinal tight junction protein regulation in infants. Additionally, his research addresses how smoking affects milk composition by increasing miR-210 expression in mammary epithelium and its implications for infant nutrition and health.

Award and Honors

Dr. Takeshi Chiba has received notable recognition for his contributions to the field of clinical pharmacology. In June 2019, he was honored with an academic award from the Iwate Society of Hospital Pharmacists, reflecting his significant achievements and impact in his area of expertise.

Research Skills

Dr. Takeshi Chiba’s research skills encompass a diverse range of expertise in clinical pharmacology, nutrition, and cell biology. He is proficient in the analysis of physiological functions, including the synthesis and secretion of norepinephrine in mammary epithelial cells and the impact of psychological stress and smoking on milk composition. Dr. Chiba is adept at investigating the regulatory effects of microRNAs on tight junction proteins in infants’ intestines. His research methods involve a combination of experimental and analytical techniques to understand and innovate in the fields of pharmacology and health science.

Publications

  1. “Smoking-induced suppression of β-casein in milk is associated with an increase in miR-210-5p expression in mammary epithelia”
    • Authors: Chiba, T., Takaguri, A., Mikuma, T., Kimura, T., Maeda, T.
    • Year: 2024
  2. “Human Milk Exosomes Induce ZO-1 Expression via Inhibition of REDD1 Expression in Human Intestinal Epithelial Cells”
    • Authors: Chiba, T., Maeda, T.
    • Year: 2023
  3. “Suppression of milk-derived miR-148a caused by stress plays a role in the decrease in intestinal ZO-1 expression in infants”
    • Authors: Chiba , T. , Takaguri , A. , Kooka , A. , Wada
    • Year: 2022
  4. “Expression profiles of hsa-miR-148a-3p and hsa-miR-125b-5p in human breast milk and infant formulae”
    • Authors: Chiba, T., Kooka, A., Kowatari, K., Sato, H., Wada, S.
    • Year: 2022
  5. “Renin-angiotensin system inhibitors may have an advantage over calcium channel blockers in reducing proteinuria in gastric cancer patients receiving ramucirumab”
    • Authors: Chiba, T., Ujiie, H., Yaegashi, Y., Tasaki, Y., Sato, H.
    • Year: 2022
  6. “Analysis of risk factors for skin disorders caused by anti-epidermal growth factor receptor antibody drugs and examination of methods for their avoidance”
    • Or
    • Year: 2021
  7. “Switching from Intravenous to Oral Tacrolimus Reduces its Blood Concentration in Paediatric Cancer Patients”
    • Authors: Ujiie, H., Nihei, S., Nishiya, N., Chiba, T., Kudo, K.
    • Year: 2021
  8. “Norepinephrine transporter expressed on mammary epithelial cells incorporates norepinephrine in milk into the cells”
    • Authors: Chiba, T., Takaguri, A., Maeda, T.
    • Year: 2021
  9. “Physiologic changes in serotonin concentrations in breast milk during lactation”
    • Authors: Maeda, T., Shioyama, A., Tairabune, T., Kudo, K., Chiba, T.
    • Year: 2020
  10. “Cancer cachexia may hinder pain control when using fentanyl patch”
    • Authors: Chiba, T., Takahashi, H., Tairabune, T., Ueda, H., Kudo, K.
    • Year: 2020

 

 

Takeshi Chiba | Life Sciences | Best Researcher Award

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *